The PCR products were then joined through overlap extension PCR (SOE PCR) at an equal mole ratio to obtain the six types of N-signal-GST-EGFP-GPI/TMDs coding regions
(), , trend or significant reduction in this parameter (weak, intermediate, or strong effect)
GLP-1 receptor agonists work by mimicking this endogenous hormone , binding to GLP-1 receptors found throughout the body, particularly in the pancreas, brain, and gastrointestinal tract

Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs To view or add a comment, sign in More Relevant Posts New Experimental Study | Diabetes & Lipid Management Can Cinnamomum zeylanicum (Ceylon cinnamon) enhance conventional therapy in diabetes

Look AHEAD Research Group, Yeh HC, Bantle JP, Cassidy-Begay M, Blackburn G, Bray GA, et al